Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Irinotecan-associated pulmonary toxicity.

Y Madarnas¹, P Webster, A M Shorter

¹Division of Medical Oncology/Hematology, Toronto-Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada. yolanda.madarnas@krcc.on.ca

Anti-Cancer Drugs

|December 29, 2000

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Health engagement sessions as a means of addressing reproductive health inequalities in a population of Afghan women during Operation ALLIED SOLACE.

BMJ military health·2022

Same author

The stability of imaging biomarkers in radiomics: a framework for evaluation.

Physics in medicine and biology·2019

Same author

Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Current oncology (Toronto, Ont.)·2019

Same author

Meat inspection for Trichinella in pork, horsemeat and game within the EU: available technology and its present implementation.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2017

Same author

Repeated inoculations with the lung and heartworm nematode <i>Angiostrongylus vasorum</i> result in increasing larval excretion and worm burden in the red fox (<i>Vulpes vulpes</i>).

International journal for parasitology. Parasites and wildlife·2017

Same author

Exploratory examination of the utility of demoralization as a diagnostic specifier for adjustment disorder and major depression.

General hospital psychiatry·2017

Irinotecan (CPT-11), a chemotherapy, can cause serious lung damage called interstitial pneumonitis. Patients with existing lung issues may face higher risks, requiring careful monitoring during treatment.

Area of Science:

Oncology
Pulmonology
Pharmacology

Background:

Colorectal cancer (CRC) treatment often involves chemotherapy.
Irinotecan (CPT-11) is a widely used chemotherapeutic agent for advanced CRC.
Previous studies indicated potential severe pulmonary complications with irinotecan use.

Observation:

A case study of a 57-year-old man with advanced CRC who developed relapsing interstitial lung disease after a single irinotecan exposure.
Initial Japanese studies reported progressive pulmonary insufficiency and death in some patients, even with steroid treatment.
US clinical trials excluded patients with compromised pulmonary function due to these risks, though ~20% still experienced cough and dyspnea.

Findings:

Irinotecan (CPT-11) is associated with interstitial pneumonitis, a severe adverse pulmonary effect.

Related Experiment Videos

The risk appears elevated in patients with pre-existing pulmonary disease.

This highlights a critical safety concern for irinotecan therapy.

Implications:

Clinicians must be vigilant for irinotecan-associated interstitial pneumonitis, especially in at-risk patients.
Expanded clinical use of irinotecan necessitates increased awareness of this potential toxicity.
Further research may be warranted to identify predictive markers and optimize management strategies for this adverse event.